Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
Joseph Mermelstein,1 Alanna Chait Mermelstein,2 Maxwell M Chait3 1Gasteroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 2Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA;...
Main Authors: | Mermelstein J, Chait Mermelstein A, Chait MM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-03-01
|
Series: | Clinical and Experimental Gastroenterology |
Subjects: | |
Online Access: | https://www.dovepress.com/proton-pump-inhibitor-refractory-gastroesophageal-reflux-disease-chall-peer-reviewed-article-CEG |
Similar Items
-
Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
by: Toshihiro Nishizawa, et al.
Published: (2020-08-01) -
Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Nur Fathurah Zamani, et al.
Published: (2022-09-01) -
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01) -
Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease Symptoms; A Randomized Double Blind Clinical Trial
by: Tarang Taghvaei, et al.
Published: (2019-01-01) -
Symptoms, the GerdQ score and patients’ characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms—results from a large prospective database
by: Joachim Labenz, et al.
Published: (2023-02-01)